Johnson Johnson (NYSE: JNJ) announced plans to invest over $55 billion in the United States over the next four years, ...

Johnson & Johnson (NYSE:JNJ) on Friday announced plans to boost its U.S. investments to more than $55B over the next four ...

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Johnson & Johnson (JNJ) and ...

智通财经APP获悉，2025年3月17日，强生 (JNJ.US)在Clinicaltrials.gov网站上注册了IL-23R口服环肽抑制剂JNJ-2113 (Icotrokinra)治疗银屑病关节炎的三期临床试验ICONIC-PsA 1。该三期临床试验计划入组540例银屑病关节炎患者，预计2026年初步完成。

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of Jim Cramer’s Latest Stock Moves: Top 10 Calls. In this article, we are going to take a look ...

First witness testifies in NYC trial over a small AI company's claim that Johnson & Johnson stole its surgical robotics tech.

Johnson & Johnson's spin-off of Kenvue has created two resilient defensive stocks in the healthcare sector, ideal for ...

In fact, they present good opportunities for investors to scoop up shares of stocks and exchange-traded funds (ETFs) that are ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

There have been few winning strategies to seek refuge in as the stock rout sparked by President Donald Trump’s start-stop ...